Satellos Bioscience Stock Market Value
| MSCLF Stock | USD 0.91 0.08 8.08% |
| Symbol | Satellos |
Satellos Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Satellos Bioscience's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Satellos Bioscience.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Satellos Bioscience on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Satellos Bioscience or generate 0.0% return on investment in Satellos Bioscience over 90 days. Satellos Bioscience is related to or competes with Imugene, Biostem Technologies, Paradigm Biopharmaceutica, Starpharma Holdings, VitaSpring Biomedical, and Kintor Pharmaceutical. Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases More
Satellos Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Satellos Bioscience's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Satellos Bioscience upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.7 | |||
| Information Ratio | 0.174 | |||
| Maximum Drawdown | 19.61 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 10.42 |
Satellos Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Satellos Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Satellos Bioscience's standard deviation. In reality, there are many statistical measures that can use Satellos Bioscience historical prices to predict the future Satellos Bioscience's volatility.| Risk Adjusted Performance | 0.1475 | |||
| Jensen Alpha | 0.9619 | |||
| Total Risk Alpha | 0.4921 | |||
| Sortino Ratio | 0.1845 | |||
| Treynor Ratio | (2.00) |
Satellos Bioscience January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1475 | |||
| Market Risk Adjusted Performance | (1.99) | |||
| Mean Deviation | 3.77 | |||
| Semi Deviation | 3.35 | |||
| Downside Deviation | 4.7 | |||
| Coefficient Of Variation | 528.94 | |||
| Standard Deviation | 4.98 | |||
| Variance | 24.81 | |||
| Information Ratio | 0.174 | |||
| Jensen Alpha | 0.9619 | |||
| Total Risk Alpha | 0.4921 | |||
| Sortino Ratio | 0.1845 | |||
| Treynor Ratio | (2.00) | |||
| Maximum Drawdown | 19.61 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 10.42 | |||
| Downside Variance | 22.07 | |||
| Semi Variance | 11.23 | |||
| Expected Short fall | (5.55) | |||
| Skewness | 0.5625 | |||
| Kurtosis | 0.315 |
Satellos Bioscience Backtested Returns
Satellos Bioscience is abnormally volatile given 3 months investment horizon. Satellos Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.2, which indicates the firm had a 0.2 % return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.0% are justified by taking the suggested risk. Use Satellos Bioscience Coefficient Of Variation of 528.94, semi deviation of 3.35, and Risk Adjusted Performance of 0.1475 to evaluate company specific risk that cannot be diversified away. Satellos Bioscience holds a performance score of 15 on a scale of zero to a hundred. The entity has a beta of -0.47, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Satellos Bioscience are expected to decrease at a much lower rate. During the bear market, Satellos Bioscience is likely to outperform the market. Use Satellos Bioscience value at risk and the relationship between the expected short fall and price action indicator , to analyze future returns on Satellos Bioscience.
Auto-correlation | -0.41 |
Modest reverse predictability
Satellos Bioscience has modest reverse predictability. Overlapping area represents the amount of predictability between Satellos Bioscience time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Satellos Bioscience price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Satellos Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Currently Active Assets on Macroaxis
Other Information on Investing in Satellos OTC Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.